Islam S, Noorani A, Sun Y, Michikawa M, Zou K
Front Aging Neurosci. 2025; 17:1535280.
PMID: 39944166
PMC: 11813892.
DOI: 10.3389/fnagi.2025.1535280.
Shan X, Li D, Yin H, Tao W, Zhou L, Gao Y
Int J Mol Sci. 2025; 26(3).
PMID: 39940973
PMC: 11818835.
DOI: 10.3390/ijms26031207.
Wan Z, Ma T
PLoS One. 2025; 20(2):e0303486.
PMID: 39913635
PMC: 11801730.
DOI: 10.1371/journal.pone.0303486.
Datta D, Arnsten A
Alzheimers Dement. 2025; 21(2):e14477.
PMID: 39776253
PMC: 11848412.
DOI: 10.1002/alz.14477.
Seddon A, MacArthur C, Hampton M, Stevens A
Redox Rep. 2024; 29(1):2428152.
PMID: 39579010
PMC: 11587723.
DOI: 10.1080/13510002.2024.2428152.
Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer's disease model.
Rao A, Chen N, Kim M, Blumenfeld J, Yip O, Liang Z
Cell Stem Cell. 2024; 32(1):86-104.e7.
PMID: 39500314
PMC: 11701721.
DOI: 10.1016/j.stem.2024.10.005.
New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer's disease.
Cao Y, Zhao L, Chen Z, Li S
Front Neurosci. 2024; 18:1430465.
PMID: 39323915
PMC: 11422391.
DOI: 10.3389/fnins.2024.1430465.
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
Liu E, Zhang Y, Wang J
Transl Neurodegener. 2024; 13(1):45.
PMID: 39232848
PMC: 11373277.
DOI: 10.1186/s40035-024-00432-x.
Temporal Characterization of the Amyloidogenic APPswe/PS1dE9;hAPOE4 Mouse Model of Alzheimer's Disease.
Grenon M, Papavergi M, Bathini P, Sadowski M, Lemere C
Int J Mol Sci. 2024; 25(11).
PMID: 38891941
PMC: 11172317.
DOI: 10.3390/ijms25115754.
Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer's disease.
Xia Z, Prescott E, Urbanek A, Wareing H, King M, Olerinyova A
Nat Commun. 2024; 15(1):4695.
PMID: 38824138
PMC: 11144216.
DOI: 10.1038/s41467-024-49028-z.
The influence of APOE on the pTau interactome in sporadic Alzheimer's disease.
Thierry M, Ponce J, Marta-Ariza M, Askenazi M, Faustin A, Leitner D
Acta Neuropathol. 2024; 147(1):91.
PMID: 38772917
PMC: 11108952.
DOI: 10.1007/s00401-024-02744-8.
Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches.
Firdaus Z, Li X
Int J Mol Sci. 2024; 25(4).
PMID: 38396996
PMC: 10889342.
DOI: 10.3390/ijms25042320.
ApoE Isoforms Inhibit Amyloid Aggregation of Proinflammatory Protein S100A9.
Ghosh S, Tamilselvi S, Williams C, Jayaweera S, Iashchishyn I, Sulskis D
Int J Mol Sci. 2024; 25(4).
PMID: 38396791
PMC: 10889306.
DOI: 10.3390/ijms25042114.
Might Diet, APOE-APOA1 Axis, and Iron Metabolism Provide Clues About the Discrepancy in Alzheimer's Disease Occurrence Between Humans and Chimpanzees? A Bioinformatics-Based Re-Analysis of Gene Expression Data on Mice Fed with Human and Chimpanzee....
Kumar A, Pal A, Singh P, Rani I, Tondolo V, Rongioletti M
Biol Trace Elem Res. 2023; 202(8):3750-3759.
PMID: 37938458
DOI: 10.1007/s12011-023-03932-5.
Patterning amyloid-β aggregation under the effect of acetylcholinesterase using a biological nanopore - an study.
Subramanian N, Watson B, Li C, Moss M, Liu C
Sens Actuators Rep. 2023; 6.
PMID: 37663321
PMC: 10469531.
DOI: 10.1016/j.snr.2023.100170.
Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele.
Ji X, Peng X, Tang H, Pan H, Wang W, Wu J
Brain Pathol. 2023; 34(1):e13208.
PMID: 37646624
PMC: 10711266.
DOI: 10.1111/bpa.13208.
Apolipoprotein E in lipid metabolism and neurodegenerative disease.
Yang L, March Z, Stephenson R, Narayan P
Trends Endocrinol Metab. 2023; 34(8):430-445.
PMID: 37357100
PMC: 10365028.
DOI: 10.1016/j.tem.2023.05.002.
Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets.
Zhang L, Xia Y, Gui Y
Front Aging Neurosci. 2023; 15:1199434.
PMID: 37333457
PMC: 10272394.
DOI: 10.3389/fnagi.2023.1199434.
Apolipoprotein E intersects with amyloid-β within neurons.
Konings S, Nyberg E, Martinsson I, Torres-Garcia L, Klementieva O, Guimas Almeida C
Life Sci Alliance. 2023; 6(8).
PMID: 37290814
PMC: 10250689.
DOI: 10.26508/lsa.202201887.
Isolation of recombinant apolipoprotein E4 N-terminal domain by foam fractionation.
Lethcoe K, Fox C, Hafiane A, Kiss R, Ryan R
Protein Expr Purif. 2023; 210:106319.
PMID: 37290717
PMC: 10330888.
DOI: 10.1016/j.pep.2023.106319.